1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CARISMA THERAPEUTICS INC

Carisma Therapeutics Inc

XNAS: CARM

Download real time

0.40 -0.01 (-2.44%)

84.96% Fall from 52W High

80,075 XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
7S
14W
1O
2T
16.7

Market Cap

Low in industry
-0.3

PE TTM

Negative PE TTM
0

PEG TTM

-1.5

Price to Book

Negative Price to Book
0.4

Beta 1Year

Very Low volatility


Insider Trading disclosures for Carisma Therapeutics Inc

The latest disclosure was made by Michael Klichinsky in Carisma Therapeutics Inc where a trade of 221,000 Stock Option (Right to Buy) done was reported to US exchanges on Jan. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael Klichinsky Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 221,000 221,000 - - Stock Option (Right to Buy)
Steven Kelly Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 500,000 500,000 - - Stock Option (Right to Buy)
Sohanya Roshan Cheng Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2024 38,700 38,700 - - Stock Option (Right to Buy)
David T. Scadden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 38,700 38,700 - - Stock Option (Right to Buy)
Marella Thorell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 38,700 38,700 - - Stock Option (Right to Buy)
John A. Hohneker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 19,350 19,350 - - Stock Option (Right to Buy)
Michael P. Torok Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 19,350 19,350 - - Stock Option (Right to Buy)
Sanford S. Zweifach Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 19,350 19,350 - - Stock Option (Right to Buy)
Briggs W. Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 19,350 19,350 - - Stock Option (Right to Buy)
Steven Kelly Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 125,000 125,000 - - Stock Option (Right to Buy)
Michael Klichinsky Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 85,000 85,000 - - Stock Option (Right to Buy)
Richard S. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 85,000 85,000 - - Stock Option (Right to Buy)
John A. Hohneker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 38,700 38,700 - - Stock Option (Right to Buy)
Morris S. Richard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 170,500 170,500 - - Stock Option (Right to Buy)
Steven Kelly Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 438,000 438,000 - - Stock Option (Right to Buy)
Klichinsky Michael Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 170,500 170,500 - - Stock Option (Right to Buy)
Michael Klichinsky Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 238,000 238,000 - - Stock Option (Right to Buy)
Chidozie Ugwumba Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 38,700 38,700 - - Stock Option (Right to Buy)
Michael P. Torok Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 38,700 38,700 - - Stock Option (Right to Buy)
Sanford S. Zweifach Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 38,700 38,700 - - Stock Option (Right to Buy)
Briggs W. Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 38,700 38,700 - - Stock Option (Right to Buy)
Steven Kelly Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 600,000 600,000 - - Stock Option (Right to Buy)
Richard S. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 238,000 238,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters